In this context, the detectability in urine11 represents an intriguing finding, which adds to the existing literature about GFAP following astrocytic injury22,23 and could assist clinicians in assessing tissue-specific outcomes following AIS. Here, GFAP is linked to androgen insensitivity syndrome.